01.10.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 download […]

01.10.2021 To the attention of interested persons EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines download document […]

27.09.2021 To the attention of interested persons EMA evaluating data on booster dose of COVID-19 vaccine Spikevax download document …

09.09.2021 To the attention of interested persons Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer download document …

06.09.2021 To the attention of interested persons EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty. download document …

03.09.2021 To the attention of interested persons Shortage of RoActemra (tocilizumab) download document …

02.09.2021 To the attention of interested persons ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines […]

24.08.2021 To the attention of interested persons Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and […]

06.08.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 August 2021 download […]

04.08.2021 To the attention of interested persons ECDC and EMA update on COVID-19: Full vaccination is key to protecting against […]